DocGo Inc.

NasdaqCM DCGO

DocGo Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2024: 9.84%

DocGo Inc. Return on Equity (ROE) is 9.84% for the Trailing 12 Months (TTM) ending September 30, 2024, a 274.65% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

DocGo Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2023 was 2.63%, a -87.19% change year over year.
DocGo Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2022 was 20.52%, a 419.81% change year over year.
DocGo Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2021 was -6.42%.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

NasdaqCM: DCGO

DocGo Inc.

CEO	Mr. Lee Bienstock
IPO Date	Dec. 17, 2020
Location	United States
Headquarters	35 West 35th Street
Employees	2,915
Sector	Health Care
Industries Telehealth Hospitals & Clinics

Description

DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.

Key trends

Past 5 years